Cytosorbents (CTSO) Other Working Capital Changes (2010 - 2026)
Cytosorbents' (CTSO) quarterly Other Working Capital Changes came in at -$1000.0 in Q1 2026, up 99.6% YoY from -$501.0 in Q1 2025, and up 99.88% on a QoQ basis from -$802000.0 in Q4 2025.
Cytosorbents (CTSO) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Other Working Capital Changes data on file, last reported at -$1000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 99.6% year-over-year to -$1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (down 342.74% YoY) and the FY2025 annual result came in at -$1.8 million, down 179000.0% from the prior year.
- Other Working Capital Changes rose to -$1000.0 in Q1 2026, from -$802000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $908000.0 in Q3 2025 to a low of -$1.6 million in Q2 2025.
- A 5-year average of -$169116.5 and a median of -$1000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 90900.0% in 2025, down 80300.0% in 2025.
- Tracing CTSO's Other Working Capital Changes over 5 years: stood at $75413.0 in 2022, then surged by 253.18% to $266343.0 in 2023, then tumbled by 99.62% to $1000.0 in 2024, then plunged by 80300.0% to -$802000.0 in 2025, then surged by 99.88% to -$1000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$1000.0 (Q1 2026), -$802000.0 (Q4 2025), and $908000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -516,000.00 |
| Jun 30, 2026 | -516,000.00 |
| Jun 30, 2026 | -516,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | -802,000.00 |
| Dec 31, 2025 | -802,000.00 |
| Dec 31, 2025 | -802,000.00 |
| Sep 30, 2025 | 908,000.00 |
| Sep 30, 2025 | 908,000.00 |
| Sep 30, 2025 | 908,000.00 |
| Jun 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | -250,000.00 |
| Mar 31, 2025 | -250,000.00 |
| Mar 31, 2025 | -250,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |